ATI RN
Cardiovascular System Exam Questions Pdf
1. Which of the following is a chronic respiratory disease characterized by the irreversible obstruction of airflow?
- A. Chronic obstructive pulmonary disease (COPD)
- B. Asthma
- C. Pulmonary edema
- D. Bronchiectasis
Correct answer: A
Rationale: The correct answer is A, Chronic obstructive pulmonary disease (COPD). COPD is a chronic respiratory disease where the airflow in the lungs becomes obstructed, making it difficult to breathe. Choice B, Asthma, is a different chronic respiratory condition characterized by reversible airflow obstruction and airway hyperresponsiveness. Choice C, Pulmonary edema, is a condition where fluid accumulates in the lungs, leading to difficulty in breathing but not irreversible airflow obstruction. Choice D, Bronchiectasis, is a condition characterized by abnormal widening of the bronchial tubes, leading to recurrent respiratory infections, but it is not specifically defined by irreversible airflow obstruction.
2. What is a condition where the arteries supplying blood to the legs and feet become narrowed or blocked, causing pain and difficulty walking?
- A. Peripheral artery disease
- B. Atherosclerosis
- C. Varicose veins
- D. Raynaud's disease
Correct answer: A
Rationale: The correct answer is A, Peripheral artery disease (PAD). PAD is characterized by the narrowing or blockage of arteries that supply blood to the legs and feet, resulting in pain and difficulty walking. Choice B, Atherosclerosis, is a condition involving the buildup of plaque in the arteries but is not specific to the legs and feet. Varicose veins (Choice C) refer to enlarged, twisted veins usually occurring in the legs. Raynaud's disease (Choice D) involves episodes of reduced blood flow to the extremities, typically triggered by cold temperatures or stress, but it is not directly related to the arteries in the legs and feet.
3. Which disease is characterized by the damage to the alveoli in the lungs, leading to breathlessness?
- A. Emphysema
- B. Pulmonary fibrosis
- C. Lung cancer
- D. Lung abscess
Correct answer: A
Rationale: The correct answer is A, Emphysema. Emphysema is a lung condition characterized by the damage to the air sacs (alveoli) in the lungs, which results in breathlessness and reduced lung function. Pulmonary fibrosis (B) is a condition where lung tissue becomes damaged and scarred, leading to stiffness in the lungs. Lung cancer (C) is a malignancy affecting the lungs, which can cause various symptoms depending on the stage. Lung abscess (D) is a localized collection of pus within the lung tissue, typically caused by a bacterial infection.
4. Which surgical procedure involves removing a portion of the lung?
- A. Lobectomy
- B. Pneumonectomy
- C. Tracheostomy
- D. Bronchoscopy
Correct answer: A
Rationale: A lobectomy is the surgical removal of a lobe of the lung. This procedure is commonly performed to treat conditions like lung cancer or severe lung diseases. Pneumonectomy involves removing an entire lung, making it incorrect. Tracheostomy is a surgical procedure to create an opening in the windpipe, not involving lung tissue removal. Bronchoscopy is a diagnostic procedure that allows visualization of the airways using a thin, flexible tube with a camera, not involving lung tissue removal.
5. The client on digoxin has a potassium level of 3.0 mEq/L. What is the nurse’s priority action?
- A. Administer a potassium supplement
- B. Hold the digoxin and notify the healthcare provider
- C. Continue the current digoxin dose
- D. Administer Digibind
Correct answer: B
Rationale: The correct answer is to hold the digoxin and notify the healthcare provider. A potassium level of 3.0 mEq/L indicates hypokalemia, which can increase the risk of digoxin toxicity. Digoxin and low potassium levels can lead to serious cardiac arrhythmias. Administering a potassium supplement (choice A) without healthcare provider guidance can worsen the situation. Continuing the current digoxin dose (choice C) can further increase the risk of toxicity. Administering Digibind (choice D) is used in severe cases of digoxin toxicity, not for addressing low potassium levels.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access